Skip to main content

Want a detailed portfolio tracker?

Galapagos (GLPG) P/E (2015 - 2026)

Galapagos (GLPG) P/E from May 14, 2015 to May 7, 2026. The TTM Galapagos (GLPG) P/E is 4.68. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Galapagos (GLPG)

YearP/EChange
20264.68-15.20%
20255.51-76.78%
202423.75-244.91%
2023-16.39-102.78%
2022588.80-2089.15%
2021-29.60+59.84%
2020-18.52-123.35%
201979.32-164.51%
2018-122.95+29.43%
2017-94.99+68.91%
2016-56.24+175.60%
2015-20.41N/A

Comparison Galapagos (GLPG) P/E with competitors

Galapagos (GLPG) P/E is 4.68.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.96%
NBYStablecoin Development Corp0.00-99.91%
ENLVEnlivex Ltd0.07-98.40%
FGENFibroGen Inc0.24-94.87%
CHRSCoherus Biosciences Inc0.85-81.86%
FBIOFortress Biotech Inc0.95-79.71%
ORMPOramed Pharmaceuticals Inc1.50-67.86%
AGENAgenus Inc3.01-35.65%
INVAInnoviva Inc3.15-32.56%
VXRTVaxart Inc3.55-24.10%
CRMDCorMedix Inc3.63-22.41%
CVACCureVac N.V.4.45-4.94%
SRPTSarepta Therapeutics Inc4.88+4.39%
ABEOAbeona Therapeutics Inc5.39+15.20%
ABUSArbutus Biopharma Corp5.60+19.65%
ZVRAZevra Therapeutics Inc5.89+25.88%
SPROSpero Therapeutics Inc6.23+33.18%
CGENCompugen Ltd6.31+35.01%
RIGLRigel Pharmaceuticals6.87+46.94%
SLXNSilexion Therapeutics Corp7.30+56.01%
OMEROmeros Corporation9.26+97.98%
AUPHAurinia Pharmaceuticals Inc9.58+104.95%
PLXProtalix BioTherapeutics Inc10.89+132.88%
ACADAcadia Pharmaceuticals Inc11.73+150.79%
TBPHTheravance Biopharma Inc12.26+162.20%
ADMAAdma Biologics Inc12.42+165.53%
HRMYHarmony Biosciences Holdings Inc13.82+195.51%
SABSSAB Biotherapeutics Inc14.14+202.27%
NAGENiagen Bioscience Inc14.82+216.85%
INCYIncyte Corp15.82+238.33%
REGNRegeneron Pharmaceuticals Inc15.86+239.06%
PBYIPuma Biotechnology Inc17.32+270.25%
CPRXCatalyst Pharmaceuticals Inc17.44+272.90%
EXELExelixis Inc17.54+275.01%
TGTXTG Therapeutics Inc18.97+305.54%
MDXGMimedx Group Inc20.55+339.47%
XOMAXOMA Royalty Corp22.87+389.13%
ARGXArgen X SE24.30+419.57%
CTMXCytomX Therapeutics Inc24.82+430.75%
XOMAOXOMA Royalty Corp25.34+441.95%
HALOHalozyme Therapeutics Inc25.62+447.92%
XOMAPXOMA Royalty Corp25.67+448.91%
VRTXVertex Pharmaceuticals Inc27.99+498.62%
RPRXRoyalty Pharma plc - Class A28.69+513.43%
SLNOSoleno Therapeutics Inc29.02+520.44%
ASNDAscendis Pharma A/S30.09+543.32%
LGNDLigand Pharmaceuticals Inc - Class B37.91+710.68%
APLSApellis Pharmaceuticals Inc39.02+734.40%
BMRNBiomarin Pharmaceutical Inc42.21+802.62%
KRYSKrystal Biotech Inc45.34+869.59%
ONCBeiGene Ltd69.54+1386.99%
PHARPharming Group N.V.75.03+1504.28%
TECHBio-Techne Corp101.96+2080.19%
VCELVericel Corp109.92+2250.46%
ALNYAlnylam Pharmaceuticals Inc117.96+2422.47%
GMABGenmab140.29+2899.86%
TLXTelix Pharmaceuticals Ltd162.15+3367.34%
CORTCorcept Therapeutics Inc212.86+4451.57%